BCPC

Balchem Corporation

122.74 USD

Last updated Nov 28, 12:12 UTC

Yesterday HIGH

$123.42

Yesterday LOW

$121.71

52w HIGH

$143.74

52w LOW

$110.74

EPS

1.04

PE

118.02

Next Earnings

Feb 23, 2024

Overview News Government Trades

Balchem Corporation stock is up 6.19% since 30 days ago. The next earnings date is Feb 23, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60.53% of the previous 37 November’s closed higher than October. 100% of analysts rate it a buy.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets. It operates through three segments: Human Nutrition, Animal Nutrition & Health, and Specialty Products. The company sells its products through sales force, independent distributors, and sales agents.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Chemicals

Headquarters

New Hampton, United States Of America

Website

balchem.com

vishwanath@benzinga.com

Mon Feb 27, 2023

HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $140

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $152 to $140.
Benzinga Newsdesk

Fri Feb 24, 2023

Balchem Q4 Adj EPS $0.94 Beats $0.83 Estimate, Sales $232.53M Miss $241.47M Estimate

Balchem (NASDAQ:BCPC) reported quarterly adj. earnings of $0.94 per share which beat the analyst consensus estimate of $0.83 by 13.25 percent. This is a 10.59 percent increase over earnings of $0.85 per share from the
Benzinga Insights

Fri Feb 24, 2023

Earnings Scheduled For February 24, 2023

Companies Reporting Before The Bell • Sprott (NYSE:SII) is expected to report earnings for its fourth quarter. • Uniti Group (NASDAQ:UNIT) is expected to report earnings for its fourth quarter.
Benzinga Insights

Thu Feb 23, 2023

Preview: Balchem's Earnings
Benzinga Insights

Mon Nov 28, 2022

Balchem's Return on Invested Capital Overview
Benzinga Newsdesk

Mon Nov 7, 2022

HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $164 to $152.
Benzinga Insights

Fri Nov 4, 2022

Recap: Balchem Q3 Earnings

Balchem (NASDAQ:BCPC) reported its Q3 earnings results on Friday, November 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Balchem beat estimated earnings by 17.65%, reporting an EPS of $1.0 versus an estimate of $0.85.
Benzinga Newsdesk

Fri Nov 4, 2022

Balchem Q3 EPS $1.00 Beats $0.85 Estimate, Sales $244.27M Beat $239.62M Estimate

Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.85 by 17.65 percent. This is a 8.7 percent increase over earnings of $0.92 per share from the same
Benzinga Insights

Fri Nov 4, 2022

Earnings Scheduled For November 4, 2022

Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $0.49 per share on revenue of $49.95 million. • Telefonica (NYSE:TEF) is likely to report earnings for its third quarter.
Benzinga Insights

Thu Nov 3, 2022

Earnings Outlook For Balchem

Balchem (NASDAQ:BCPC) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement. Analysts estimate that Balchem will report an earnings per share (EPS) of $0.85.